R&D | April 16, 2026
NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
In his new role, Karthik will lead human capital strategy and HR operations across these regions
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The goal is to better support drug developers as programs move from laboratory research into clinical trials
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Subscribe To Our Newsletter & Stay Updated
